Elisa Cerretani

3PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 23, 2024
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells.

Jaco A C van Bruggen, Fleur S Peters, Morris Mes

|Jun 04, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Matteo Marchesini, Andrea Gherli, Elisa Simoncini

|Jan 23, 2024
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

Luca Pagliaro, Elisa Cerretani, Federica Vento

Pageof 1